| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
INSERM, U-515, Hôpital Saint-Antoine (M.H., R.Z., P.L., B.D., C.B., L.P., Y.L.B.), 75571 Paris, France; and INSERM, U-380, Faculté de Médecine Cochin-Port Royal (G.H.), 75014 Paris, France
Address all correspondence and requests for reprints to: Dr. Martin Holzenberger, INSERM, U-515, Hôpital Saint Antoine, 75571 Paris Cedex 12, France. E-mail: holzenberger{at}st-antoine.inserm.fr
Reduced IGF type I receptor levels diminish postnatal growth rate
and adult body weight in mice. Here, we studied the impact of
experimental IGF receptor deficiency on tissue-specific growth by
Cre-lox-mediated dosage of a floxed
IGF-IR gene. We generated mice with a wide spectrum of receptor
deficiency (582%), and separated them into two groups with either
strong (
50%) IGF-IR deficiency (XS mice) or moderate deficiency
(<50%, M mice). The growth of XS mice was significantly retarded from
3 wk after birth onward, with respect to M littermates. This
effect was twice as strong in males as in females. Growth deficits
persisted throughout adult life, and at 1012 months, most organs and
tissues showed specific weight defects. Skin, bone and connective
tissue, muscle, spleen, heart, lung, and brain were the most severely
affected organs in the XS males. With the exception of muscle and
spleen, the same tissues were also significantly reduced in size in
females, although to a lesser extent. The most severe growth defect,
however, concerned adipose tissue. Fat pad size in XS males was
only 29% (females, 44%) of M mice. The estimated number of adipocytes
in XS male fat pads was only 21% that of M males (XS
female, 27%). Lipid content per cell was significantly higher in XS
adipocytes, whereas plasma glucose and insulin levels were low in
XS males. Thus, IGF type I receptor deficiency produced mice with
disproportionate postnatal organ growth, and these effects depended
strongly on sex. A marked reduction in IGF-IR levels resulted in a
major defect in adipose tissue.
This article has been cited by other articles:
![]() |
P. Touraine, G. A D'Souza, I. Kourides, R. Abs, P. Barclay, R. Xie, A. Pico, E. Torres-Vela, B. Ekman, and the GH Lipoatrophy Study Group Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH Eur. J. Endocrinol., October 1, 2009; 161(4): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ohlsson, S. Mohan, K. Sjogren, A. Tivesten, J. Isgaard, O. Isaksson, J.-O. Jansson, and J. Svensson The Role of Liver-Derived Insulin-Like Growth Factor-I Endocr. Rev., August 1, 2009; 30(5): 494 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fang, I. D. Schwartz, B. D. Johnson, M. A. Derr, C. T. Roberts Jr., V. Hwa, and R. G. Rosenfeld Familial Short Stature Caused by Haploinsufficiency of the Insulin-Like Growth Factor I Receptor due to Nonsense-Mediated Messenger Ribonucleic Acid Decay J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1740 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kappeler, C. De Magalhaes Filho, P. Leneuve, J. Xu, N. Brunel, C. Chatziantoniou, Y. Le Bouc, and M. Holzenberger Early Postnatal Nutrition Determines Somatotropic Function in Mice Endocrinology, January 1, 2009; 150(1): 314 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Sutherland, S. E. Knoblaugh, P. J. Kaplan-Lefko, F. Wang, M. Holzenberger, and N. M. Greenberg Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium Cancer Res., May 1, 2008; 68(9): 3495 - 3504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Duffield, T. Vuocolo, R. Tellam, B. S. Yuen, B. S. Muhlhausler, and I. C. McMillen Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1413 - R1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Hurov, M. Huang, L. S. White, J. Lennerz, C. S. Choi, Y.-R. Cho, H.-J. Kim, J. L. Prior, D. Piwnica-Worms, L. C. Cantley, et al. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo PNAS, March 27, 2007; 104(13): 5680 - 5685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Svensson, M Diez, J Engel, C Wass, A Tivesten, J-O Jansson, O Isaksson, T Archer, T Hokfelt, and C Ohlsson Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J. Endocrinol., June 1, 2006; 189(3): 617 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Raile, J. Klammt, A. Schneider, A. Keller, S. Laue, R. Smith, R. Pfaffle, J. Kratzsch, E. Keller, and W. Kiess Clinical and Functional Characteristics of the Human Arg59Ter Insulin-Like Growth Factor I Receptor (IGF1R) Mutation: Implications for a Gene Dosage Effect of the Human IGF1R J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2264 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sadagurski, S. Yakar, G. Weingarten, M. Holzenberger, C. J. Rhodes, D. Breitkreutz, D. LeRoith, and E. Wertheimer Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol. Cell. Biol., April 1, 2006; 26(7): 2675 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Svensson, B. Soderpalm, K. Sjogren, J. Engel, and C. Ohlsson Liver-derived IGF-I regulates exploratory activity in old mice Am J Physiol Endocrinol Metab, September 1, 2005; 289(3): E466 - E473. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du Gender modulates cardiac phenotype development in genetically modified mice Cardiovasc Res, August 15, 2004; 63(3): 510 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Unger, S. D. Chernausek, W. Kiess, and R. J. Smith IGF-I Receptor Mutations and Intrauterine and Postnatal Growth Retardation N. Engl. J. Med., March 25, 2004; 350(13): 1362 - 1363. [Full Text] [PDF] |
||||
![]() |
Y. Okubo, K. Siddle, H. Firth, S. O'Rahilly, L. C. Wilson, L. Willatt, T. Fukushima, S.-I. Takahashi, C. J. Petry, T. Saukkonen, et al. Cell Proliferation Activities on Skin Fibroblasts from a Short Child with Absence of One Copy of the Type 1 Insulin-Like Growth Factor Receptor (IGF1R) Gene and a Tall Child with Three Copies of the IGF1R Gene J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5981 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sekimoto and C. M. Boney C-Terminal Src Kinase (CSK) Modulates Insulin-Like Growth Factor-I Signaling through Src in 3T3-L1 Differentiation Endocrinology, June 1, 2003; 144(6): 2546 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Galvan, A. Logvinova, S. Sperandio, H. Ichijo, and D. E. Bredesen Type 1 Insulin-like Growth Factor Receptor (IGF-IR) Signaling Inhibits Apoptosis Signal-regulating Kinase 1 (ASK1) J. Biol. Chem., April 4, 2003; 278(15): 13325 - 13332. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Leneuve, S. Colnot, G. Hamard, F. Francis, M. Niwa-Kawakita, M. Giovannini, and M. Holzenberger Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles Nucleic Acids Res., March 1, 2003; 31(5): e21 - e21. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |